Sparse Modeling enables highly accurate AI models, even when trained with small amounts (frugal) of data. HACARUS’ award-winning AI technology provides a more efficient and resource-friendly alternative to conventional AI techniques.
Human users are able to understand HACARUS’ AI models decision making process, unlike other conventional AI techniques. By understanding the rationale behind AI decision making, it is possible to accelerate the development of future applications.
HACARUS’ AI can be easily integrated into a variety of different environments and does not require a dedicated hardware (GPU) or cloud connectivity, allowing it to be run in existing operations at customers’ sites (CPU).
AI Enabled Cerebral Infarction Diagnosis Assistance – HACARUS & Ohara Pharmaceutical
HACARUS and the University of Tokyo join forces for AD/PD drug discovery
Mitsubishi Electric’s Future Vision for Manufacturing – Advancing Factory Automation with HACARUS using Cutting Edge Technology
Case Study：Yanmar
Case Study：Hitachi Zosen
Vets Invited to Test ECG Monitoring Device by HACARUS and DS Pharma Animal Health
HACARUS Brings Sparse Modeling to Drug Discovery with Mitsubishi Tanabe Pharma
Osaka Gas’s Approach to DX – Collaborating with HACARUS to bring innovative solutions to customers
